RE: France31 Jan 2021 14:50
Discussions
'We were able to treat with inhaled IFN-ß-1b, on a compassionate basis, four patients with severe COVID-19 admitted in the intensive care unit. Neither antibiotic nor hCQ administration had provided a satisfactory therapeutic response in these patients with severe co-morbidities. They showed an improvement in clinical and biochemical parameters within an acceptable time frame, in the absence of treatment-related adverse events. All of them were discharged from hospital and subsequently resumed normal life after a period of rehabilitation. Based on these observations, it seems reasonable to assume that inhaled IFN-ß has exerted an antiviral action by restoring deficient pulmonary innate immunity defenses.,'
COMPASSIONATE BASIS...are the guys in Burton getting it out there...?